It can be treated, say researchers—but only if diagnosed
Search results for: Primary care
Drug Updates
Information on New Approvals and Medication Safety
What You See Is What You Get: Transparency in Industry relationships
Transparency in industry relationships
Mitigate Risk and Increase Success of Lupus Clinical Trials
Design strategies from a Lupus Research Institute conference
Advocating for Arthritis: My First Time on the Hill
Amidst the most momentous week of the year’s tumultuous healthcare reform activities, we arrived in Washington, D.C., for the annual ACR Advocates for Arthritis Capitol Hill Fly-In. This was to be my first visit to Congress. Although my alma mater, Georgetown University, was a short distance from the Capitol dome, as a student I had little interest in the political process—particularly as it related to medicine. Now, however, as a young rheumatologist, I am increasingly aware of the impact health policy has on my daily practice. I have also watched the healthcare reform debate unfold over the last year, recognizing that this is a critical time for physicians to be vocal and active. There is a great deal at stake, and we are surrounded daily by the very issues debated in Washington. Why not take our opinions directly to the decision makers?
Annual Meeting Looks at the Business of Rheumatology
In response to the need for education to help a busy practicing rheumatologist tackle some of the business tasks associated with practice, the 2010 Annual Meeting Planning Committee has created a new track: the Business of Rheumatology. This track was created to help the busy private practitioner identify sessions that address pertinent and timely business issues, such as coding, reimbursement, the impact of healthcare reform, EHRs, and other business-related issues.
Leaders in Washington, D.C., Addresses Advocates for Arthritis Conference
This spring, 120 rheumatologists, rheumatology health professionals, and patient advocates travelled to Washington, D.C., for the ACR’s annual Advocates for Arthritis conference.
Cardiovascular Disease Risk High in RA Patients
High incidence of metabolic disease and concurrent inflammation increases risk
Drug Updates
Information on New Approvals and Medication Safety
Bridge the Gap Between Goal and Attainment
Use motivational interviewing to facilitate behavior change for your clients
- « Previous Page
- 1
- …
- 128
- 129
- 130
- 131
- 132
- …
- 136
- Next Page »